COVID-19

Healthcare consolidation paves way for care delivery changes

Clarivate U.S. market access experts discuss on recent mergers, cause of these mergers and their impact on the healthcare system. Read more.  Changes in the U.S. healthcare industry, many of which were prompted by the pandemic, are driving consolidations to cover gaps in care and stabilize revenue streams. Payers are engaging in non-traditional mergers, such as the announcement by UnitedHealth Group’s Optum unit to buy Change Healthcare to strengthen its analytics, technology and revenue cycle management capabilities. Payers […]

Three key trends in regulatory approvals of new medicines

A new study by the Centre for Innovation in Regulatory Science (CIRS) has shown that despite regulatory convergence over the last 20 years, there are still differences in approval times across global regulatory agencies. The following article summarizes key findings from the latest CIRS R&D Briefing, New drug approvals in six major authorities 2011-2020. Three […]

Impact of COVID-19 on patient volumes, procedure utilization and site of service

The COVID-19 pandemic has had a negative impact on healthcare patient volumes, procedure utilization and sites of service, and the effect has varied by procedure urgency. In this article, Clarivate analysts detail which procedures and sites fared the best and which are most likely to recover as more of the population is vaccinated, a critical […]

How will COVID-19 vaccine rollout differ by country?

COVID-19 vaccination represents a critical component in the recovery of medtech markets for healthcare capacity, patient mobility and the full restoration of global manufacturing operations and supply chains. To understand the effect of various vaccination campaigns, we need to understand the rollout by region and country. Clarivate experts developed a vaccination forecast model to illustrate […]

Time to get even – the value of research diversity

The latest ISI report identifies a new way to calculate and compare how well nations and institutions could respond to unforeseen challenges, based on the diverse spread of research areas in their portfolios ‘Diversity’ has long been a watchword in fields such as economics and ecology, and in recent years has gained prominence in the […]

Impact of COVID-19 vaccine rollout on medtech recovery

The COVID-19 pandemic impacted the fundamental operations of all healthcare stakeholders. The ability to predict the outcomes of the pandemic and the speed of recovery for medtech markets has been challenged by the lack of historical data. This article is an executive summary of a new report from Clarivate assessing how COVID-19 vaccine rollouts will […]

COVID-19 vaccines: Social media user sentiments and strategies to encourage administration

Although the pandemic continues to influence lives around the world, recent advances in vaccine development and distribution offer hope for relief. However, there is still uncertainty and misinformation surrounding the efficacy and safety of the vaccines. Clarivate experts Shubhita Thukraal and Vyshnavi Manda uncover consumer and healthcare worker attitudes based on analysis of social media […]

Women’s leadership and COVID-19: Spotlight on Alison Isherwood

In honor of Women’s History Month, throughout March we’re putting a special focus on the incredible role women researchers and scientists have played in addressing COVID-19 and creating a more equitable STEM field post-pandemic. At Clarivate, more than half of the colleagues in our science organization are women. Their achievements are invaluable to our contributions […]

Women’s leadership and COVID-19: Spotlight on Garima Kaul

In honor of International Women’s Day and Women’s History Month, throughout March we’re putting a special focus on the incredible role women researchers and scientists have played in addressing COVID-19 and creating a more equitable STEM field post-pandemic. At Clarivate, more than half of the colleagues in our science organization are women. Their achievements are […]